Ann: Letter to Shareholders, page-80

Don't expect too much!

BIT announcement on COVID 19 March Last year was mere distraction........? you need to ask this question from BIT......as a year and half gone without any outcome but why?

A letter of update is only the tool left for BIT. Where is the product? Where is FDA approval? Many smaller and large companies from developing and developed nations were successful in developing and delivering vaccines for COVID-19 but what about BIT? What about its compounds?.....

Again, don't expect too much.....nothing but waste of time.....

DOR